UBS Group
AGN

UBS Group’s Allergan plc AGN Stock Holding History

UBS Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-25,000
Closed -$4.43M – 8715
2020
Q1 		$4.43M Sell
25,000
-130,000
-84% -$24.5M ﹤0.01% 2032
2019
Q4 		$29.6M Sell
155,000
-2,700
-2% -$487K 0.01% 1102
2019
Q3 		$26.5M Buy
157,700
+34,800
+28% +$5.67M 0.01% 1051
2019
Q2 		$20.6M Buy
122,900
+50,400
+70% +$6.98M 0.01% 1202
2019
Q1 		$10.6M Sell
72,500
-43,000
-37% -$6.23M ﹤0.01% 1633
2018
Q4 		$15.4M Buy
115,500
+3,000
+3% +$492K 0.01% 1263
2018
Q3 		$21.4M Sell
112,500
-130,000
-54% -$23.9M 0.01% 1158
2018
Q2 		$40.4M Sell
242,500
-160,000
-40% -$25.7M 0.02% 758
2018
Q1 		$67.7M Sell
402,500
-85,400
-18% -$14.3M 0.03% 510
2017
Q4 		$79.8M Sell
487,900
-2,398,500
-83% -$430M 0.03% 488
2017
Q3 		$592M Buy
2,886,400
+2,731,600
+1,765% +$635M 0.27% 81
2017
Q2 		$37.6M Buy
154,800
+41,000
+36% +$9.63M 0.02% 706
2017
Q1 		$27.2M Sell
113,800
-4,600
-4% -$1.07M 0.01% 845
2016
Q4 		$24.9M Sell
118,400
-67,900
-36% -$14.1M 0.01% 900
2016
Q3 		$42.9M Buy
186,300
+86,000
+86% +$21M 0.03% 585
2016
Q2 		$23.2M Sell
100,300
-25,200
-20% -$5.81M 0.01% 849
2016
Q1 		$33.6M Sell
125,500
-185,900
-60% -$53.2M 0.02% 616
2015
Q4 		$97.3M Buy
311,400
+310,600
+38,825% +$92.5M 0.06% 313
2015
Q3 		$217K Sell
800
-1,600
-67% -$491K ﹤0.01% 4568
2015
Q2 		$728K Sell
2,400
-3,800
-61% -$1.13M ﹤0.01% 3822
2015
Q1 		$1.84M Hold
6,200
– – ﹤0.01% 3004
2014
Q4 		$1.59M Buy
+6,200
New +$1.55M ﹤0.01% 3123

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

UBS Group's AGN Position: Q2 2020 in Review

UBS Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,853,356 shares — an estimated $1.21B sold.

UBS Group first reported a position in AGN in Q4 2014 and held it in 22 quarters. The position peaked at $1.23B in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • UBS Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • UBS Group sold 6,853,356 Allergan plc shares in Q2 2020, an estimated $1.21B.
  • UBS Group first reported a position in Allergan plc in Q4 2014 and held it in 22 quarters.
  • UBS Group's Allergan plc position peaked at $1.23B in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.